戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                              The belief that enteric-coated and buffered varieties are less likely to
2 (Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic
3        The relative risks of UGIB for plain, enteric-coated, and buffered aspirin at average daily do
4                          Exposure of mice to enteric-coated antigen promotes an extensive T helper 2-
5                                They received enteric-coated ASA after ulcer healing.
6  if still resistant were exposed to low-dose enteric coated aspirin (81 mg) and clopidogrel (75 mg) f
7 parent resistance to a single dose of 325-mg enteric coated aspirin (up to 49%) but not to immediate
8 gle oral dose of 325-mg immediate release or enteric coated aspirin.
9 lowing 7-day regimens in a crossover design: enteric-coated aspirin 100 mg twice daily, enteric-coate
10 : enteric-coated aspirin 100 mg twice daily, enteric-coated aspirin 200 mg once daily, or plain aspir
11 endoscopy were assigned randomly to placebo, enteric-coated aspirin 81 mg/day, rofecoxib 25 mg combin
12 in; there were insufficient data to evaluate enteric-coated aspirin at this dose level.
13 re ibuprofen (400 mg three times a day); and enteric-coated aspirin two hours before delayed-release
14 d the same medications in the reverse order; enteric-coated aspirin two hours before ibuprofen (400 m
15 ized mice with oral allergen, in the form of enteric-coated beads, resulted in marked allergen-specif
16 yed and reduced drug absorption, complicates enteric coated but not immediate release aspirin adminis
17                  Oral delivery of devices in enteric coated capsules resulted in significant bioavail
18 irectly into the intestine of cats by use of enteric-coated capsules.
19 nd ritonavir for 7 days, (B) zidovudine plus enteric-coated didanosine for 30 days, or (C) regimen 1
20 and postpartum regimens: (A) zidovudine plus enteric-coated didanosine plus lopinavir and ritonavir f
21 phous solid-state form, and the integrity of enteric-coated drug delivery systems.
22  lipid-based aspirin), and a delayed-release enteric-coated (EC) aspirin.
23  We aimed to establish in vivo evidence that enteric-coated (EC) calcium is bioavailable in pregnant
24 duce the gastrointestinal effects of MMF, an enteric-coated formulation of the drug was developed, ba
25              IL-11 was administered daily by enteric, coated multiparticle pellets over the course of
26                       Conversion from SRL to enteric coated mycophenolate sodium led to an increase i
27 rospective trial with conversion from SRL to enteric coated mycophenolate sodium.
28 ity to absorb cyclosporin, tacrolimus (Tac), enteric-coated mycophenolate sodium (EC-MPS) and sirolim
29 mplaints from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) has not bee
30 nversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in terms of
31 nversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) significant
32  long-term outcomes of patients who received enteric-coated mycophenolate sodium (EC-MPS) versus myco
33  (GI) complications in patients treated with enteric-coated mycophenolate sodium (EC-MPS) versus myco
34                It was of interest to compare enteric-coated mycophenolate sodium (EC-MPS) versus myco
35                                     Although enteric-coated mycophenolate sodium (EC-MPS) was develop
36 nsisting of reduced tacrolimus dosing (rTd), enteric-coated mycophenolate sodium (EC-MPS), and early
37       In this study, the IEM was combined to enteric-coated mycophenolate sodium (ECMPS).
38 olate mofetil (group A, n=75) versus 1.440 g enteric-coated mycophenolate sodium (group B, n=75), wit
39  first long-term, randomized trial comparing enteric-coated mycophenolate sodium versus mycophenolate
40 l equivalents) was significantly higher with enteric-coated mycophenolate sodium versus mycophenolate
41                          Use of low doses of enteric-coated or buffered aspirin carries a three-fold
42                   Once daily 100 mg aspirin (enteric coated) or placebo.
43  approach to characterize the quality of the enteric-coated peptide product.
44 ers ingested either a placebo or a partially enteric-coated preparation of bovine immunoglobulins wit
45 ) and an oral formulation of this API within enteric-coated sucrose spheres.
46  replication-deficient, orally administered, enteric-coated, vaccinia virus-vectored vaccine might sa

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。